Patent · US Expired

Pharmaceutical compositions for the treatment of hydropic conditions

US3963834A · kind A · utility

1Cited by

0References

24Claims

0Family size

Assignee

Boehringer Mannheim GmbH · DE

Inventors

Rolf Kuhn · Ingelheim am Rhein, DE
Klaus Hardebeck
Helmut Heinemann · Kelkheim, DE
Knut Osmers

Key dates

Filing date	Apr 18, 1975
Grant date	Jun 15, 1976
Priority date	—
Expiry date	Apr 18, 1995

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising PA1 A. at least one member of the group consiting of 5-(4-chloro-5-sulfamoyl-2-thenylaminophenyl)-tetrazole and the pharmacologically compatible salts thereof PA1 B. at least one member of the group consisting of 3-(3-oxo-17.beta.-hydroxy-4,6-androstadien-17.alpha.-yl)-propionic acid-.gamma.-lactone and the pharmacologically compatible salts of 3-(3-oxo-17.beta.-hydoxy-4,6-androstadien-17.alpha.-yl)-propionic acid, and a pharmaceutical carrier; Possess outstanding activity for treating hydropic conditions and prevent undesirable increased excretion of potassium without at the same time impairing the desired excretion of water and sodium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.